StonvexLoading…
StonvexStonvexStonvexCore line items from TGTX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $204.92M | $616.29M | $423.71M | $262.00M |
Operating Income | $34.80M | $123.32M | $72.83M | $43.47M |
Net Income | $19.78M | $447.18M | $424.14M | $28.19M |
EPS (Diluted) | $0.12 | $2.77 | $2.62 | $0.20 |
Total Assets | $1.53B | $1.06B | $1.03B | $702.61M |
Total Liabilities | $945.71M | $415.23M | $417.81M | $426.18M |
Cash & Equivalents | $442.21M | $79.15M | $74.08M | $129.13M |
Free Cash Flow OCF − CapEx | $-17.95M | $-24.99M | $-44.58M | $-21.35M |
Shares Outstanding | 153.09M | 155.31M | 155.21M | 158.03M |